Robert Shawah
Founder chez ACURX PHARMACEUTICALS, INC.
Fortune : 463 540 $ au 31/03/2024
Profil
Robert G.
Shawah is the founder of Acurx Pharmaceuticals, Inc. (founded in 2017) and holds the title of Chief Financial Officer.
He also held the position of Director at Ameri100 Holdco, Inc. in 2018.
Prior to that, he served as Treasurer & Chief Accounting Officer at Dipexium Pharmaceuticals, Inc. from 2014 to 2017.
Additionally, he was Vice President & Partner at Baldwin Pearson & Co., Inc. in 2013.
Mr. Shawah obtained his undergraduate degree from Bucknell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/04/2024 | 189 200 ( 1,31% ) | 463 540 $ | 31/03/2024 |
Postes actifs de Robert Shawah
| Sociétés | Poste | Début |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Founder | 01/07/2017 |
Anciens postes connus de Robert Shawah
| Sociétés | Poste | Fin |
|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Director/Board Member | 01/12/2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/04/2017 |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01/01/2013 |
Formation de Robert Shawah
| Bucknell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
| Baldwin Pearson & Co., Inc. |
